{"version":"1.0","type":"link","title":"The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.","author_name":"Mujollari J 외","author_url":"https://prs-insight.online/author/Mujollari%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160295","thumbnail_width":1200,"thumbnail_height":630}